Notice 3 Jul 2025 compliance, information collection, regulation, fda, tobacco

🚬FDA Notice on Warning Plans for Tobacco Products

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection provisions associated with warning plans for certain tobacco products.

Learn More
Rule 3 Jul 2025 regulation, aviation, faa, incorporation by reference, north carolina, airspace, navigation (air), coastal carolina regional airport

✈️Airspace Regulation Changes at Coastal Carolina Regional Airport

This action amends Class D and Class E airspace at Coastal Carolina Regional Airport, New Bern, NC, due to the current designated airspace not properly containing instrument flight rule operations. Additionally, this action amends Class E4 airspace at Coastal Carolina Regional Airport, New Bern, NC, due to portions no longer meeting the requirements of its designation. Lastly, this action amends the Class E5 airspace that no longer meets the requirements for its specific designation due to the amendment or cancellation of Standard Instrument Approach Procedures. Controlled airspace is necessary for the safety and management of IFR operations in the area for existing instrument approaches.

Learn More
Notice 3 Jul 2025 regulation, banking, federal reserve, bank control, acquisition, shareholders

🏦Change in Bank Control Notices

The Federal Reserve announces new applications under the Change in Bank Control Act related to acquisitions of shares in banks and bank holding companies. It outlines the public comment process, inspection of applications, and disclosure of comments, emphasizing transparency in the regulatory framework. Interested parties can submit their views and obtain application details from respective Federal Reserve Banks.

Learn More
Proposed Rule 3 Jul 2025 compliance, regulation, epa, food safety, pesticide, agricultural

🌱Regulatory Notice on Pesticide Petitions and Business Implications

This document announces the Agency's receipt of and solicits public comment on initial filings of pesticide petitions requesting the establishment or modification of regulations for residues of pesticide chemicals in or on various commodities. The Agency is providing this notice in accordance with the Federal Food, Drug, and Cosmetic Act (FFDCA). EPA uses the month and year in the title to identify when the Agency compiled the petitions identified in this notice of filing. Unit II. of this document identifies certain petitions received in 2023, 2024 and 2025 that are currently being evaluated by EPA, along with information about each petition, including who submitted the petition and the requested action.

Learn More
Notice 3 Jul 2025 compliance, safety standards, regulation, transportation, united states, railroad, canada, air brakes

🚂Notice of Waiver Petition for Air Brake Compliance in Rail Transport

This document provides the public notice that Canadian Pacific Kansas City Limited (CPKC) and Union Pacific Railroad (UP) petitioned FRA for relief from certain regulations concerning air brake testing.

Learn More
Rule 3 Jul 2025 compliance, regulation, financial institutions, antitrust, fdic, bank mergers

🏦FDIC Reinstates Prior Bank Merger Policy for Clarity and Compliance

The FDIC is taking final action to rescind the Statement of Policy on Bank Merger Transactions published in 2024 (2024 Statement of Policy) and reinstate its Statement of Policy on Bank Merger Transactions that was in effect prior to the 2024 Statement of Policy (Bank Merger Statement of Policy). The reinstated Bank Merger Statement of Policy will remain in effect pending the FDIC's review of all aspects of the regulatory framework governing the FDIC's review of merger transactions in connection with a future proposal to comprehensively revise its merger policy.

Learn More
Notice 3 Jul 2025 compliance, regulation, finance, federal reserve, acquisitions, georgia, mergers, tennessee, bank holding company

🏦Federal Reserve Notice on Bank Holding Companies Mergers and Acquisitions

The Federal Reserve System issued a notice regarding applications for the formation, acquisition, and merger of bank holding companies. It details the public disclosure process for comments and outlines the regulatory oversight under the Bank Holding Company Act. Interested parties are invited to submit their views on the applications before a specified deadline.

Learn More
Notice 3 Jul 2025 regulation, securities, financial services, nasdaq, etf, cryptocurrency, dogecoin

📈Nasdaq Proposes Rule Change for 21Shares Dogecoin ETF Trading

The Securities and Exchange Commission has extended the review period for Nasdaq's proposed rule change to list and trade shares of the 21Shares Dogecoin ETF. This decision allows for further consideration of the proposal and reflects the ongoing evolution in cryptocurrency investment within regulated markets, highlighting industry interest in innovative financial products.

Learn More
Notice 3 Jul 2025 regulation, securities, public comments, cryptocurrency, cboe bzx exchange

💹SEC Regulatory Notice on Osprey Bitcoin Trust Trading Proposal

The SEC has initiated proceedings to evaluate a proposed rule change by Cboe BZX Exchange for listing and trading shares of the Osprey Bitcoin Trust. This involves assessing the proposed Trust's compliance with existing regulations and soliciting public comments to inform the decision-making process. Stakeholders are encouraged to provide written feedback regarding potential issues and the implications of this proposal on market integrity.

Learn More
Notice 3 Jul 2025 healthcare, regulation, pharmaceuticals, fda, drug approvals

💊FDA Determines SYNDROS Not Withdrawn, Opens Doors for Generics

The Food and Drug Administration (FDA, Agency, or we) has determined that SYNDROS (dronabinol) solution, 5 milligrams (mg)/ milliliter (mL), was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for SYNDROS (dronabinol) solution, 5 mg/ mL, if all other legal and regulatory requirements are met.

Learn More